Pre-publication history
Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study
-
* Corresponding author: Yanhong Wang wang.yanhong@zs-hospital.sh.cn
BMC Medicine 2009, 7:41 doi:10.1186/1741-7015-7-41
Pre-publication versions of this article and reviewers' reports
| Resubmission - Version 2 | Manuscript | Author's comment | 24 Jun 2009 |
| Editorial acceptance | 24 Jun 2009 | ||
| Published | 24 Aug 2009 | ||
| Editor's comment | Editor's comment | 11 Nov 2009 |